CClinicalTrials.gg
Status unknownNCT04789226Updated Mar 9, 2021

Psychological Impact of Covid-19 Assiut University Hospital Experience

An observational study in Psychological Impact of Covid-19, sponsored by Assiut University. Status unknown. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-03-09.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
239
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Psychological impact of covid-19 in assiut university hospital

Read the detailed description

Coronavirus disease 2019 (COVID-19) is a new communicable disease caused by the new strains of severe acute respiratory syndrome coronavirus, SARS-CoV-2 . The first outbreak reported was in December2019, in Wuhan, China, as pneumonia of unknown etiology linked to a seafood market exposure COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.

The evolution of the novel Corona Virus Disease (COVID-19) and its expeditious dissemination have led the World Health Organization (WHO) to declare it a pandemic on 11 March 2020 . As of 16 May 2020, there have been 4,425,485 confirmed COVID-19 cases and 302,059 related deaths worldwide and Egypt has been among the most affected countries in the Eastern Mediterranean region with 11,228 confirmed cases and 592 deaths .

As a consequence, many countries, including Egypt, have set a state of lockdown to hinder the spread of infection among people resulting in a global atmosphere of depression and anxiety associated with social isolation, fears of getting infected, breaks in the supply chains, financial distress, disrupted travel plans, and future uncertainty . Several epidemiological studies from China detected a high prevalence of psychological disturbances among the public during the COVID-19 pandemic. For example, a large online survey of 56,679 individuals from 34 provinces in China reported numerous psychological conditions during the COVID-19 pandemic: depression (27.9%), anxiety (31.6%), stress (24.4%), and insomnia (29.2%) . Also, a study conducted on 4872 Chinese people from 31 provinces showed a high prevalence of depression (48.3%) and anxiety (22.6%) related to the COVID-19 pandemic . A similar study revealed depression (20.1%), anxiety (35.1%), and poor sleeping (18.2%) among 7236 Chinese people . Another study conducted on 7143 college students in China detected anxiety among 25% of them .

In low- and middle-income countries, such as Egypt, where infection control precautions, surveillance programs, laboratory capacity, and public health resources are limited , the response to the COVID-19 pandemic is challenging and, as a result, the psychological impacts of the pandemic on the public can be even worse. Thus, we conducted this study to evaluate several forms of psychological disturbances .

02

Conditions studied

  • Psychological Impact of Covid-19

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 239 is close to the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients more than 18 years old and less than 90 years old diagnosed as covid-19 by positive PCR

Inclusion criteria

  • age more than 18 years old
  • diagnosed as covid-19 by positive PCR
  • comes to Assiut University Hospital
  • both sex males and females

Exclusion criteria

Exclusion Criteria:

  • age less than 18 years old
  • past history of psychatric disorder
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
239 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Symptom Checklist 90 "SCL 90"

    it is a 90 item questionnaire used to assess psychological problems .

    Time frame: One year

  2. post traumatic stress disorder "PTSD"

    PCL-5 is a 20 item self report measure that assesses the 20 DSM-5 symptoms of PTSD .

    Time frame: One year

  3. Pittsburgh Sleep Quality Index "PSQI"

    evaluating sleep quality in older adults , the pittsburgh sleep quality index can be used to detect sleep disturbance or deficits .

    Time frame: One year

  4. The 36- items Short Form"SF 36"

    consists of eight scaled scores , which are the weighted sums of the questions in their section " evaluating individual patients health status " .

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04789226
Lead sponsor
Assiut University
Responsible party
Esraa Yassin Ibrahim (Principal investigator, Assiut University) — Principal investigator
First posted
Mar 9, 2021
Start date
Mar 1, 2021 (estimated)
Primary completion
Mar 1, 2022 (estimated)
Completion
Mar 1, 2022 (estimated)
Last update
Mar 9, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion